This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kanashiro, C. A. Articles by Khalil, R. A. Search for Related Content PubMed PubMed Citation Articles by Kanashiro, C. A. Articles by Khalil, R. A.

(Hypertension. 1999;34:924-930.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Ca²⁺-Insensitive Vascular Protein Kinase C During Pregnancy and NOS Inhibition

Celia A. Kanashiro; Barbara T. Alexander; Joey P. Granger; Raouf A. Khalil

From the Department of Physiology and Biophysics and the Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson.

Correspondence to Raouf A. Khalil, MD, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216-4505. E-mail rkhalil{at}physiology.umsmed.edu

Abstract—Pregnancy-induced hypertension is associated with increased vascular resistance; however, the cellular mechanisms involved are unclear. We have previously found that the relation between Ca²⁺ entry and the developed force in vascular smooth muscle is altered during normal pregnancy and in a rat model of pregnancy-induced hypertension produced by long-term treatment with the nitric oxide synthase inhibitor N^G-nitro-L-arginine methyl ester (L-NAME). The purpose of this study was to investigate whether the pregnancy-associated changes in the vascular Ca²⁺ entry-force relation reflect changes in the amount and/or activity of Ca²⁺-insensitive protein kinase C (PKC) isoforms. Active stress and the amount and activity of PKC were measured in deendothelialized aortic strips from nonpregnant and pregnant rats untreated or treated with L-NAME and incubated in Ca²⁺-free (2 mmol/L EGTA) Krebs solution. In nonpregnant rats, the PKC activator phorbol 12,13-dibutyrate (PDBu, 10^-6 mol/L) and the -adrenergic agonist phenylephrine (Phe, 10^-5 mol/L) caused significant, maintained increases in active stress and PKC activity that were inhibited by the PKC inhibitors staurosporine and calphostin C. Western blots in aortic strips of nonpregnant rats revealed the Ca²⁺-insensitive -PKC and -PKC isoforms. Both PDBu and Phe caused translocation of -PKC from the cytosolic to the particulate fraction. Compared with nonpregnant rats, the amount of -PKC and -PKC and the PDBu-stimulated and Phe-stimulated stress, PKC activity and translocation of -PKC were significantly reduced in late pregnant rats but significantly enhanced in pregnant rats treated with L-NAME. The PDBu-induced and Phe-induced responses in nonpregnant rats treated with L-NAME were not significantly different from nonpregnant rats, whereas the responses in pregnant rats treated with L-NAME+L-arginine were not significantly different from pregnant rats. These results provide evidence that a signaling pathway in vascular smooth muscle possibly involving the Ca²⁺-insensitive -PKC and -PKC isoforms is reduced in late pregnancy and enhanced during long-term inhibition of nitric oxide synthesis. The changes in the amount and activity of vascular PKC isoforms may, in part, explain the changes in vascular resistance during normal pregnancy and pregnancy-induced hypertension.

Key Words: nitric oxide • muscle, smooth, vascular • hypertension, pregnancy • preeclampsia

This article has been cited by other articles:

				K. Chang, D. Xiao, X. Huang, L. D. Longo, and L. Zhang Chronic hypoxia increases pressure-dependent myogenic tone of the uterine artery in pregnant sheep: role of ERK/PKC pathway Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1840 - H1849. [Abstract] [Full Text] [PDF]

				W. Chen and R. A. Khalil Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1962 - R1972. [Abstract] [Full Text] [PDF]

				K. Chang and Lubo Zhang Review Article: Steroid Hormones and Uterine Vascular Adaptation to Pregnancy Reproductive Sciences, April 1, 2008; 15(4): 336 - 348. [Abstract] [PDF]

				P. Li, H. Jiang, L. Yang, S. Quan, S. Dinocca, F. Rodriguez, N. G. Abraham, and A. Nasjletti Angiotensin II induces carbon monoxide production in the perfused kidney: relationship to protein kinase C activation Am J Physiol Renal Physiol, November 1, 2004; 287(5): F914 - F920. [Abstract] [Full Text] [PDF]

				M.-H. Wang, J. Wang, H.-H. Chang, B. A. Zand, M. Jiang, A. Nasjletti, and M. Laniado-Schwartzman Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats Am J Physiol Renal Physiol, August 1, 2003; 285(2): F295 - F302. [Abstract] [Full Text] [PDF]

				R. A. Khalil and J. P. Granger Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R29 - R45. [Abstract] [Full Text] [PDF]

				P. Rocic, T. M. Griffin, C. N. McRae, and P. A. Lucchesi Altered PYK2 phosphorylation by ANG II in hypertensive vascular smooth muscle Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H457 - H465. [Abstract] [Full Text] [PDF]